Abemaciclib is a small molecule which can act as a CDK 4/6 inhibitor. It is provided as a powder.
This product acts on the following target types: Kinase, Cytochrome.
This product acts on the following biochemical pathways: Cell cycle, Apoptosis inducer, Intracellular transport.
This product may be interest in the following research areas and diseases: Cell death, Cancer, Inflammation.
Please note that our chemical products are for research use only in a laboratory and are not for medical or veterinary use.